Dalagon, Deborah N.
HRN: 13-28-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2024
CEFTRIAXONE 1G (VIAL)
02/17/2024
02/29/2024
IVT
2g
OD
T/c Complicated UTI, T2DM Poorly Controlled With Complications
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes